Brand-specific estimates of influenza vaccine effectiveness for the 2021–2022 season in Europe: results from the DRIVE multi-stakeholder study platform

INTRODUCTION: Development of Robust and Innovative Vaccine Effectiveness (DRIVE) was a European public–private partnership (PPP) that aimed to provide annual, brand-specific estimates of influenza vaccine effectiveness (IVE) for regulatory and public health purposes. DRIVE was launched in 2017 under...

Descripción completa

Detalles Bibliográficos
Autores principales: Stuurman, Anke L., Carmona, Antonio, Biccler, Jorne, Descamps, Alexandre, Levi, Miriam, Baum, Ulrike, Mira-Iglesias, Ainara, Bellino, Stefania, Hoang, Uy, de Lusignan, Simon, Bonaiuti, Roberto, Lina, Bruno, Rizzo, Caterina, Nohynek, Hanna, Díez-Domingo, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399959/
https://www.ncbi.nlm.nih.gov/pubmed/37546295
http://dx.doi.org/10.3389/fpubh.2023.1195409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399959/
https://www.ncbi.nlm.nih.gov/pubmed/37546295
http://dx.doi.org/10.3389/fpubh.2023.1195409

Ejemplares similares